Abstract: A system and method are provided to monitor and prevent potential enterprise policy and/or rule violations by subscribers.

Abstract: A system and method are provided to monitor and prevent potential enterprise policy and/or rule violations by subscribers.

Abstract: A system and method are provided to monitor and prevent potential enterprise policy and/or rule violations by subscribers. A node filters requests to send a selected communication and/or content and/or provide a nonsubscriber with access to the selected communication and/or content against plurality trusted groupings to determine if the nonsubscriber is a member of a trusted group. The nonsubscriber is provided with the selected communication and/or content when he or she is a trusted group member and restricted from receiving and/or accessing the at least a portion of the selected communication and/or content when he or she is not in a trusted group or is in a trusted group not privileged to receive the information. The nonsubscriber can be a member of multiple trusted groups, based on the nature of the relationship of the nonsubscriber with the enterprise.

Abstract: A system and method are provided to monitor and prevent potential enterprise policy and/or rule violations by subscribers.

Abstract: A system and method are provided to monitor and prevent potential enterprise policy and/or rule violations by subscribers.

Abstract: A system and method are provided to monitor and prevent potential enterprise policy and/or rule violations by subscribers.

Abstract: A system and method are provided to monitor and prevent potential enterprise policy and/or rule violations by subscribers.

Abstract: A system and method are provided to monitor and prevent potential enterprise policy and/or rule violations by subscribers.

Abstract: The synthesis and use of a novel class of tumor necrosis factor (TNF?) inhibitors and immunomodulators are provided. These compounds have pharmacological applications as well as uses in assays relating to TNF? and other involved cytokines. As pharmaceuticals, these compounds are used to treat inflammatory, infectious, autoimmune or other proliferative diseases and conditions related to the unwanted presence or activity of TNF? and/or one or more other involved cytokines, alone or in combination with other agents.

Abstract: The synthesis and use of a novel class of tumor necrosis factor (TNF&agr;) inhibitors and immunomodulators are provided. These compounds have pharmacological applications as well as uses in assays relating to TNF&agr; and other involved cytokines. As pharmaceuticals, these compounds are used to treat inflammatory, infectious, autoimmune or other proliferative diseases and conditions related to the unwanted presence or activity of TNF&agr; and/or one or more other involved cytokines, alone or in combination with other agents.

Abstract: In order to cool heat generating components on an electronic assembly without contamination by particles carried in a cooling gas stream, a cold plate is disposed adjacent the assembly, defining a gap region therebetween. The cooling gas is directed in proximity to the cold plate, dissipating heat transferred from the components to the plate. To enhance overall heat dissipation of the apparatus, an aperture is defined between the gap region and the gas stream, so that a negative pressure is induced in the gap by virtue of the Bernoulli principle. This pressure difference induces convection within the gap, increasing heat flow between the components and the plate, and resulting in overall improvement in heat dissipation. Embodiments in which the gas stream flow is parallel and transverse to the cold plate are described.